For most people, genetic testing is worth it when there’s a specific clinical reason to do it, such as a strong family history of cancer, a child with unexplained developmental delays, or planning a pregnancy with a known risk. Without that context, the value drops considerably. The answer depends on what type of test you’re considering, what you hope to learn, and what you’d actually do with the results.
What Genetic Testing Can Actually Tell You
Genetic testing isn’t one thing. It spans a wide range, from consumer DNA kits you order online to clinical-grade sequencing ordered by a specialist. Each type answers different questions, with different levels of reliability.
Clinical genetic testing, the kind ordered through a healthcare provider, looks for specific changes in your DNA linked to known diseases. For rare and undiagnosed conditions in children, whole genome sequencing identifies a cause about 34% of the time, compared to roughly 18% for older, less comprehensive methods. That may sound modest, but for families who’ve spent years without answers, a one-in-three chance of a definitive diagnosis can be life-changing. It can end a grueling diagnostic journey, connect families with the right specialists, and sometimes reveal treatments that wouldn’t have been considered otherwise.
Consumer DNA kits from companies like 23andMe or AncestryDNA offer health reports alongside ancestry data, but they test only a small selection of genetic variants. Their accuracy for the variants they do test is high, with greater than 99% concordance compared to clinical-grade methods. The problem is what they leave out. A consumer test might check for three BRCA variants common in people of Ashkenazi Jewish descent while missing thousands of other harmful BRCA changes. A “negative” result from a consumer kit doesn’t mean you’re in the clear.
Where Testing Has the Clearest Payoff
The strongest case for genetic testing exists when the results would directly change your medical care or life planning. A few scenarios stand out.
Cancer risk. If you carry a harmful BRCA1 or BRCA2 variant, your lifetime risk of breast and ovarian cancer is substantially higher than average. Knowing this opens the door to earlier and more frequent screening, preventive medications, or risk-reducing surgery. Women with BRCA variants who have used oral contraceptives, for example, have about a 50% lower risk of ovarian cancer compared to those who haven’t. These aren’t abstract statistics. They’re decisions you can make years before cancer would ever develop.
Family planning. Carrier screening checks whether you and your partner both carry a recessive gene for conditions like cystic fibrosis, sickle cell disease, or spinal muscular atrophy. You can be a carrier without ever having symptoms yourself, but if both parents carry the same condition, each pregnancy has a 25% chance of being affected. Among couples who learned they were both carriers during a current pregnancy, 64% chose to have the fetus tested. For couples who aren’t yet pregnant, knowing carrier status ahead of time opens options like IVF with embryo screening or using a donor.
Undiagnosed conditions. For children with developmental delays, seizures, or other unexplained symptoms, genetic testing can finally put a name to what’s happening. Even when there’s no cure, a diagnosis helps families access the right therapies, connect with support communities, and stop undergoing unnecessary procedures in search of answers.
The Limits You Should Know About
Nearly 20% of genetic tests return what’s called a variant of uncertain significance, or VUS. This means the lab found a DNA change, but there isn’t enough evidence yet to say whether it’s harmful or harmless. A VUS doesn’t give you a clear direction. You can’t act on it the way you’d act on a confirmed harmful variant, and it can sit in a gray zone for years before scientists gather enough data to reclassify it.
Research from the National Cancer Institute found that women who received a VUS result reported an increase in cancer-specific distress. That said, the overall psychological picture was mostly reassuring. Across all result types, including harmful findings and uncertain ones, participants who went through genetic counseling reported feeling less anxious and depressed after testing than before. The key ingredient was counseling. People who understood what their results meant, and what they didn’t mean, handled the information well.
This points to an important distinction. Clinical genetic testing almost always includes pre-test and post-test counseling with a genetics professional. Consumer kits don’t. If you’re using a consumer test and it flags something concerning, you’ll need clinical confirmation before making any medical decisions.
What It Costs and What Insurance Covers
Consumer DNA kits typically run $100 to $300 out of pocket. Clinical genetic testing ranges from a few hundred dollars for a single-gene test to several thousand for whole genome sequencing.
Insurance coverage varies widely and depends on medical necessity. Medicare, for instance, covers BRCA testing only for patients who already have signs of disease, not for unaffected family members. Coverage also requires that genetic counseling has been performed before the test and is planned afterward. For multi-gene panels, every gene on the panel must be relevant to your personal and family history. Large panels stuffed with irrelevant genes won’t be covered.
Private insurers generally follow similar logic: if your personal or family history meets established guidelines for testing, coverage is likely. If you’re simply curious, you’ll probably pay out of pocket. Many testing labs offer financial assistance programs or payment plans, so it’s worth asking before assuming you can’t afford it.
Privacy Risks Are Real but Specific
A federal law called the Genetic Information Nondiscrimination Act (GINA) prevents health insurers and employers from using your genetic information against you. Your health insurance company can’t raise your premiums or deny you coverage based on a genetic test result, and your employer can’t use it in hiring or firing decisions.
The gap is significant, though. GINA does not cover life insurance, long-term care insurance, or disability insurance. If you test positive for a high-risk variant, insurers in these categories can legally factor that into their decisions in most states. Some states have passed additional protections, but coverage is uneven. If you’re considering applying for life or long-term care insurance, it may be worth doing so before undergoing genetic testing.
When Testing Probably Isn’t Worth It
If you have no family history of genetic conditions, no symptoms that suggest an underlying genetic cause, and no specific medical question you’re trying to answer, the yield from clinical testing is low. Consumer kits can be fun for ancestry exploration, but their health reports are limited in scope and can generate worry without providing actionable information.
Testing also has less value when you wouldn’t change your behavior based on the results. If learning you have an elevated genetic risk for a condition wouldn’t lead you to pursue earlier screening, adjust your family planning, or consider preventive options, the information may create anxiety without a clear benefit. The worth of a genetic test is ultimately tied to what you do with the answer.